March 21st 2025
Fitch Ratings has downgraded two hospitals that suffered cyberattacks. Other hospitals could face downgrades if they have lasting damage from attacks.
Medical Crossfire®: The Experts Bridge Recent Data in Chronic Lymphocytic Leukemia With Real-World Sequencing Questions
View More
The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy
View More
Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care
View More
Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®
View More
Exploring the Benefits and Risks of AI in Oncology
View More
BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
View More
Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting
View More
Contextualizing Advances in Relapse Refractory DLBCL: Navigating Biomarkers, Emerging Data, and Adverse Event Management to Transform Patient Care
View More
Burst CME™: Tackling Adverse Events With Targeted Therapies for Diffuse B-Cell Lymphoma
View More
Biomarkers in Diffuse Large B-Cell Lymphoma: Empowering Treatment Decisions to Improve Outcomes
View More
Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches
View More
BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?
View More
Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: How is the Newly Approved CAR T-Cell Therapy Impacting R/R B-Cell ALL Management?
View More
Cybersecurity: How the World Measures Up, Country by Country
July 6th 2017The UN has released its annual report on global cybersecurity. The report aims to measure which countries are most committed to making the web more secure, scoring countries according to five pillars: technical, organizational, legal, cooperation and growth potential.
Should Healthcare Systems Be Concerned About Hidden Cobra?
June 21st 2017Another week, another IT security threat with a conveniently catchy name: the U.S. Department of Health and Human Services late last week released a warning about a new threat, or series of threats, that could impact healthcare systems.
ReadyDock's David Engelhardt on Technology to Kill MRSA, C. Diff
March 1st 2017In Part 2 of his interview with HCA News, David Engelhardt, the founder of ReadyDock Inc., discussed the company's chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. Here, Engelhardt details how ReadyDock’s technology works and infection-causing bacteria it can kill.
ReadyDock's David Engelhardt Talks Hospital-Acquired Infections
March 1st 2017David Engelhardt, the founder of ReadyDock Inc., met up with HCA News for an interview at the HIMSS17 conference in Orlando, Florida. ReadyDock is chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. In this section, Engelhardt speaks of the severity and complexity of the infection issue.
Trivalent Unveils New Data Protection Service for Healthcare Enterprises
February 23rd 2017Trivalent has released a new encryption and file shredding technology, Trivalent Protect, at the HIMSS17 meeting. The new service, which works with the Windows OS, uses AES256 bit encryption and was labeled as the "next-generation" of data protection by the company.
Yiannis Vassiliades on Security Risks that Health IT Must Address
February 23rd 2017At HIMSS17 in Orlando, Florida, Yiannis Vassiliades of Trivalent spoke with HCA News about the cybersecurity risks associated with the healthcare industry, giving a basic example of the potential problems seen in day-to-day life and detailing his background in IT security and his organization’s aims.
Spectralink CMO Ashish Sharma on Creating Better Hospital Communication Devices
February 23rd 2017At HIMSS17 in Orlando, Florida, HCA News spoke with Ashish Sharma, Chief Marketing Officer at Spectralink. Spectralink's communications technology is nearly ubiquitous in hospitals, and Sharma discussed the move from simple, utilitarian devices to the creation of new, integrated touchscreen units.
Stuart Goldberg of Cota: "Value-based medicine is the rage."
February 10th 2017Goldberg sat down with Healthcare Analytics News to discuss the platform’s goal of delivering real-world data to oncology departments in order to expedite transitions to value-based models and provide attuned patient care.